With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Please provide your email address to receive an email when new articles are posted on . Both incidence and mortality rates for uterine cancer are expected to increase through 2050. Black women will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results